Every 3 months, during a regularly scheduled clinic visit (if participant is still receiving care at MD Anderson) or by phone (if participant is receiving care outside of MD Anderson), participant will be asked how participant is doing, if participant is still taking ibrutinib, and if participant has any side effects. If called, this call should last about 5-10 minutes.